Evidence map›Paper›PMID 37997351›Full record

ArticleJournal of the International Association of Providers of AIDS Care

Melissa Vera, Elizabeth Bukusi, Pauline Achieng, Helen Aketch, Evelyne Araka, Jared M Baeten, Kristin Beima-Sofie, Grace John-Stewart, Pamela K Kohler, Melissa L Mugambi and 6 more

Abstract read
In one paragraph

Article in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Melissa VeraSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0002-9208-6248
Elizabeth BukusiSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.
Pauline AchiengKenya Medical Research Institute, Kisumu, Kenya.
Helen AketchKenya Medical Research Institute, Kisumu, Kenya.
Evelyne ArakaKenya Medical Research Institute, Kisumu, Kenya.
Jared M BaetenSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.
Kristin Beima-SofieSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.
Grace John-StewartSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.
Pamela K KohlerSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0001-6176-6374
Melissa L MugambiSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.
Bernard NyerereKenya Medical Research Institute, Kisumu, Kenya.
Josephine OdoyoKenya Medical Research Institute, Kisumu, Kenya.
Caroline OmomKenya Medical Research Institute, Kisumu, Kenya.
Christine OmondiKenya Medical Research Institute, Kisumu, Kenya.
Katrina F OrtbladGilead Sciences, Foster City, CA, USA.
Jillian PintyeSchool of Nursing and Department of Global Health, University of Washington, Seattle, WA, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Evaluating Infant PrEP Exposure During Pregnancy and BreastfeedingR01HD100201 · NICHD · UNIVERSITY OF WASHINGTON · PI PINTYE, JILLIAN · 2019 to 2023
$3.4M
Evaluating sexually transmitted infections among adolescent girls and young women within a pharmacy-based PrEP delivery model in Kenya.R01HD108041 · NICHD · UNIVERSITY OF WASHINGTON · PI BUKUSI, ELIZABETH ANNE, PINTYE, JILLIAN · 2021 to 2025
$3.3M
mWACh-PrEP: A SMS-based Support Intervention to Enhance PrEP Adherence during Pregnancy and BreastfeedingR01NR019220 · NINR · UNIVERSITY OF WASHINGTON · PI KINUTHIA, JOHN, PINTYE, JILLIAN · 2020 to 2024
$2.9M
RiNGH (Research in Nursing & Global Health) Training ProgramT32NR019761 · NINR · UNIVERSITY OF WASHINGTON · PI KOHLER, PAMELA, PINTYE, JILLIAN · 2021 to 2025
$1.4M
Peer PrEP referral + HIV self-test for PrEP initiation among young Kenyan womenR00MH121166 · NIMH · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ORTBLAD, KATRINA FRANCES · 2021 to 2024
$866k
Pharmacy delivery to expand the reach of PrEP in KenyaR34MH120106 · NIMH · UNIVERSITY OF WASHINGTON · PI ORTBLAD, KATRINA FRANCES · 2019 to 2020
$605k
The design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settingsK01MH122326 · NIMH · UNIVERSITY OF WASHINGTON · PI MUGAMBI, MELISSA · 2021 to 2024
$582k
NIAID NIH HHS P30 AI027757NICHD NIH HHS R01 HD100201NICHD NIH HHS R01 HD108041NIMH NIH HHS K01 MH122326NIMH NIH HHS R00 MH121166NIMH NIH HHS R34 MH120106NINR NIH HHS R01 NR019220NINR NIH HHS T32 NR019761
6 · The paper itself

Abstract

introductionMany Kenyan adolescent girls and young women (AGYW) with behaviors associated with HIV acquisition access contraception at retail pharmacies. Offering oral pre-exposure prophylaxis (PrEP) in pharmacies could help reach AGYW with PrEP services.

methodsWe piloted PrEP delivery at 3 retail pharmacies in Kisumu, Kenya. AGYW purchasing contraception were offered PrEP by nurses with remote prescriber oversight. AGYW who accepted were provided with a free 1-month supply. We conducted in-depth interviews with AGYW 30 days postobtaining PrEP. Transcripts were analyzed to explore experiences of AGYW accessing PrEP at pharmacies.

resultsWe conducted 41 interviews. AGYW preferred pharmacies for accessing PrEP and they were willing to pay for PrEP even if available for free at clinics. Reasons for this preference included accessibility, lack of queues, and medication stockouts, privacy, anonymity, autonomy, and high-quality counseling from our study nurses.

conclusionsPharmacies may be an important PrEP access option for this population.

Indexed as

Anti-HIV AgentsHIV InfectionsPharmaciesPharmacyPre-Exposure ProphylaxisAdolescentFemaleHumansKenyaAnti-HIV AgentsadolescentscontraceptionHIV preventionpharmacyPrEP

Identifiers

PMID37997351
PMCPMC10676062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.